StonvexLoading…
StonvexStonvexStonvexCore line items from ACAD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.07B | $957.80M | $726.44M | $517.24M |
Operating Income | $104.81M | $230.79M | $-73.38M | $-223.60M |
Net Income | $391.00M | $226.45M | $-61.29M | $-215.97M |
EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 |
Total Assets | $1.56B | $1.19B | $748.96M | $587.81M |
Total Liabilities | $336.81M | $454.96M | $317.20M | $187.40M |
Cash & Equivalents | $177.69M | $319.59M | $188.66M | $114.85M |
Free Cash Flow OCF − CapEx | $105.15M | $157.20M | $16.65M | $-114.03M |
Shares Outstanding | 170.31M | 166.71M | 164.65M | 162.06M |